Cannabidiol, a cannabis sativa constituent, as an antipsycholic drug (2006)
- Authors:
- USP affiliated authors: ZUARDI, ANTONIO WALDO - FMRP ; CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP ; GUIMARÃES, FRANCISCO SILVEIRA - FMRP
- Unidade: FMRP
- DOI: 10.1590/s0100-879x2006000400001
- Subjects: ESQUIZOFRENIA; ANTIPSICÓTICOS; CANNABIS (EFEITOS); ANSIEDADE
- Language: Inglês
- Imprenta:
- Publisher place: Ribeirão Preto
- Date published: 2006
- Source:
- Título do periódico: Brazilian Journal of Medical and Biological Research
- ISSN: 0100-879X
- Volume/Número/Paginação/Ano: v. 39, p. 421-429, 2006
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
ZUARDI, A. W. et al. Cannabidiol, a cannabis sativa constituent, as an antipsycholic drug. Brazilian Journal of Medical and Biological Research, v. 39, p. 421-429, 2006Tradução . . Disponível em: https://doi.org/10.1590/s0100-879x2006000400001. Acesso em: 08 jun. 2024. -
APA
Zuardi, A. W., Crippa, J. A. de S., Hallak, J. E. C., Moreira, F. A., & Guimarães, F. S. (2006). Cannabidiol, a cannabis sativa constituent, as an antipsycholic drug. Brazilian Journal of Medical and Biological Research, 39, 421-429. doi:10.1590/s0100-879x2006000400001 -
NLM
Zuardi AW, Crippa JA de S, Hallak JEC, Moreira FA, Guimarães FS. Cannabidiol, a cannabis sativa constituent, as an antipsycholic drug [Internet]. Brazilian Journal of Medical and Biological Research. 2006 ; 39 421-429.[citado 2024 jun. 08 ] Available from: https://doi.org/10.1590/s0100-879x2006000400001 -
Vancouver
Zuardi AW, Crippa JA de S, Hallak JEC, Moreira FA, Guimarães FS. Cannabidiol, a cannabis sativa constituent, as an antipsycholic drug [Internet]. Brazilian Journal of Medical and Biological Research. 2006 ; 39 421-429.[citado 2024 jun. 08 ] Available from: https://doi.org/10.1590/s0100-879x2006000400001 - Effects of minocycline on regional cerebral blood flow in schizophrenia
- Canabidiol: possíveis aplicacões terapêuticas em psicopatologias
- A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation
- Possible therapeutic uses of cannabidiol in anxiety disorders and schizophrenia
- Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder
- Is the highest density of CB1 receptors in paranoid schizophrenia a correlate of endocannabinoid system functioning?
- Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus
- Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders
- Administration of harmine and imipramine alters creatine kinase and mitochondrial respiratory chain activities in the rat brain
- Cannabidiol normalizes caspase 3, synaptophysin, and mitochondrial fission protein DNM1L expression levels in rats with brain iron overload: implication for neuroprotection
Informações sobre o DOI: 10.1590/s0100-879x2006000400001 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
